Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TherapeuticsMD Inc TXMD

Healthcare
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD... see more

Recent & Breaking News (NDAQ:TXMD)

TherapeuticsMD Reports Second Quarter 2013 Financial Results

Business Wire August 6, 2013

TherapeuticsMD Added to 2013 Russell Indexes

Business Wire July 1, 2013

TherapeuticsMD to Present at JMP Securities Healthcare Conference

Business Wire June 26, 2013

TherapeuticsMD Investigational New Drug Filing Accepted By FDA

Business Wire June 14, 2013

TherapeuticsMD to Ring Opening Bell at NYSE

Business Wire June 12, 2013

TherapeuticsMD to Present at Jefferies 2013 Global Healthcare Conference

Business Wire May 28, 2013

TherapeuticsMD Elects Jules A. Musing to Board of Directors

Business Wire May 16, 2013

TherapeuticsMD Reports First Quarter 2013 Financial Results

Business Wire May 8, 2013

TherapeuticsMD Announces Trading of Its Common Stock on the NYSE MKT Under Symbol "TXMD"

Business Wire April 22, 2013

TherapeuticsMD Announces Pricing of Public Offering of Common Stock

Business Wire March 15, 2013

TherapeuticsMD Announces $50,000,000 Proposed Public Offering of Common Stock

Business Wire March 7, 2013

BUYINS.NET Updates TherapeuticsMD SqueezeTrigger Report

Troy Schwensen January 3, 2013